S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
ASX:PTX

Prescient Therapeutics (PTX) Stock Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free PTX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
537,831 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.88%
Price Target
N/A
Stock Analysis
Stock Analysis
PTX stock logo

About Prescient Therapeutics Stock (ASX:PTX)

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. The company was incorporated in 1986 and is based in Melbourne, Australia.

PTX Stock News Headlines

April 18, 2024 | msn.com
Prescient Management Expands Portfolio with Additional PMXINC Securities Listing
April 6, 2024 | msn.com
Prescient Management Expands PIPETF Securities in the Market
April 19, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
April 4, 2024 | msn.com
Prescient ETF Expands Offering with Additional Securities Listing
March 26, 2024 | msn.com
Prescient ETF Expands with New Listings in Global Property Portfolio
March 15, 2024 | msn.com
Prescient ETF Expands with New Securities Listing
March 6, 2024 | finance.yahoo.com
We're Hopeful That Prescient Therapeutics (ASX:PTX) Will Use Its Cash Wisely
February 1, 2024 | afr.com
Prescient Therapeutics Limited
April 19, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
December 10, 2023 | au.investing.com
Prescient Therapeutics’ PTX-100 Phase 1b study shows excellent safety and promising efficacy in T-cell lymphoma patients
November 20, 2023 | msn.com
MoneyTalks: Prescient set for ‘big pay day’; Aerometrex to grab ‘blue ocean’ AI opportunity
November 16, 2023 | proactiveinvestors.com.au
Prescient Therapeutics nearing a potential payday with PTX-100: Pitt Street Research
November 6, 2023 | au.investing.com
Prescient Therapeutics to participate in prestigious conference; abstract online now
October 31, 2023 | msn.com
Cancer fighter Prescient navigates challenging conditions for biotech, reports strong Q1 FY24
October 17, 2023 | msn.com
Prescient prepares to unveil Phase 1b cancer trial findings at world’s largest haematology conference
October 16, 2023 | proactiveinvestors.com.au
Prescient Therapeutics to present clinical data at prestigious US conference
September 19, 2023 | msn.com
ASX cancer stocks guide: Here’s everything you need to know
August 30, 2023 | msn.com
‘Above and beyond approved therapies’: How Prescient Therapeutics is at the forefront of cancer fighting
June 16, 2023 | finance.yahoo.com
Prescient Therapeutics showcases cell therapy data at prestigious ISCT conference
May 15, 2023 | proactiveinvestors.com.au
Prescient Therapeutics to present CellPryme and OmniCAR data to International Society of Cell and Gene Therapy
May 15, 2023 | proactiveinvestors.com.au
Prescient Therapeutics bolsters board with appointment of experienced US-based pharma executive
April 20, 2023 | finance.yahoo.com
Prescient Therapeutics (ASX:PTX) Is In A Good Position To Deliver On Growth Plans
March 16, 2023 | proactiveinvestors.com.au
Prescient Therapeutics' PTX-100 T Cell Lymphoma Phase 1b trial continues to show promising results
March 15, 2023 | msn.com
ASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good results
March 9, 2023 | proactiveinvestors.com.au
Prescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100
March 8, 2023 | msn.com
Guess which ASX biotech stock just rocketed 29% on big FDA news
March 8, 2023 | proactiveinvestors.com
Prescient Therapeutics granted US FDA additional Orphan Drug Designation for PTX-100; shares up
See More Headlines
Receive PTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prescient Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:PTX
CUSIP
N/A
CIK
N/A
Web
www.ptxtherapeutics.com
Phone
61 3 9692 7222
Fax
N/A
Employees
171
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,740,000.00
Net Margins
-248.74%
Pretax Margin
N/A
Return on Equity
-32.67%
Return on Assets
-20.79%

Debt

Debt-to-Equity Ratio
0.81
Current Ratio
10.26
Quick Ratio
17.31

Sales & Book Value

Annual Sales
$3.11 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.91
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
805,320,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.07
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Steven Lee Yatomi-Clarke
    MD, CEO & Director
  • Ms. Melanie Jaye Leydin B.Bus (Age 51)
    C.A., CFO & Company Secretary
    Comp: $158.4k
  • Ms. Leanne West
    Director of Clinical Affairs & Operations
  • Dr. Terrence G. Chew (Age 77)
    Chief Medical Officer
    Comp: $155.99k
  • Ms. Rebecca Lim
    Senior Vice President of Scientific Affairs

Key Competitors

View All Competitors

Insiders


PTX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Prescient Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prescient Therapeutics investors own include SkyCity Entertainment Group (SKC) and Findi (FND).

This page (ASX:PTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends